PHS
IQV icon

PFM Health Sciences’s IQVIA IQV Stock Holding History

PFM Health Sciences’s Portfolio IQV Stock Details IQV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,852
Closed -$8.53M – 91
2025
Q4 		$8.53M Buy
+37,852
New +$8.24M 0.85% 39
2025
Q2 		– Sell
-111,854
Closed -$19.7M – 67
2025
Q1 		$19.7M Hold
111,854
– – 1.43% 24
2024
Q4 		$22M Hold
111,854
– – 1.36% 23
2024
Q3 		$26.5M Hold
111,854
– – 1.5% 23
2024
Q2 		$23.7M Hold
111,854
– – 1.17% 31
2024
Q1 		$28.3M Hold
111,854
– – 1.33% 29
2023
Q4 		$25.9M Sell
111,854
-89,183
-44% -$18.3M 1.55% 23
2023
Q3 		$39.6M Hold
201,037
– – 1.86% 24
2023
Q2 		$45.2M Hold
201,037
– – 1.75% 24
2023
Q1 		$40M Sell
201,037
-28,044
-12% -$5.99M 1.77% 21
2022
Q4 		$46.9M Hold
229,081
– – 1.68% 20
2022
Q3 		$41.5M Buy
229,081
+7,385
+3% +$1.62M 1.5% 27
2022
Q2 		$48.1M Hold
221,696
– – 1.84% 17
2022
Q1 		$51.3M Sell
221,696
-16,343
-7% -$3.87M 1.92% 18
2021
Q4 		$67.2M Sell
238,039
-119,877
-33% -$31.1M 2.29% 11
2021
Q3 		$85.7M Hold
357,916
– – 2.52% 11
2021
Q2 		$86.7M Hold
357,916
– – 2.72% 9
2021
Q1 		$69.1M Sell
357,916
-15,385
-4% -$2.89M 2.11% 13
2020
Q4 		$66.9M Buy
373,301
+35,314
+10% +$5.95M 2.35% 8
2020
Q3 		$53.3M Buy
337,987
+50,449
+18% +$7.91M 2.46% 8
2020
Q2 		$40.8M Buy
287,538
+130,337
+83% +$17.7M 2.12% 15
2020
Q1 		$17M Sell
157,201
-186,366
-54% -$26.6M 1.39% 29
2019
Q4 		$53.1M Sell
343,567
-133,435
-28% -$19.5M 2.53% 14
2019
Q3 		$71.3M Sell
477,002
-161,324
-25% -$25.1M 2.1% 13
2019
Q2 		$103M Buy
638,326
+361,517
+131% +$50.7M 1.95% 12
2019
Q1 		$39.8M Buy
+276,809
New +$36.9M 0.88% 39

Other funds holding IQV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

PFM Health Sciences's IQV Position: Q1 2026 in Review

PFM Health Sciences sold out of IQVIA (IQV) in Q1 2026, closing a stake of 37,852 shares — an estimated $8.53M sold.

PFM Health Sciences first reported a position in IQV in Q1 2019 and held it in 26 quarters. The position peaked at $103M in Q2 2019. 1,071 funds tracked by Wall St. Rank hold IQV as of Q1 2026.

  • PFM Health Sciences reported no remaining IQVIA position as of Q1 2026 after selling out during the quarter.
  • PFM Health Sciences sold 37,852 IQVIA shares in Q1 2026, an estimated $8.53M.
  • PFM Health Sciences first reported a position in IQVIA in Q1 2019 and held it in 26 quarters.
  • PFM Health Sciences's IQVIA position peaked at $103M in Q2 2019.
  • 1,071 funds tracked by Wall St. Rank held IQVIA as of Q1 2026.

Based on PFM Health Sciences's 13F filing for Q1 2026, filed 15 May 2026.